WILMINGTON – Pharmaceutical giant AstraZeneca sold the rights to two of its drugs used in the treatment of chronic obstructive pulmonary disease (COPD) for $270 million, the company announced Nov. […]
© 2024 Delaware Business Times
Important notice for access to your Delaware Business Times “Insider” content
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.
SUMMER FLASH SALE!
Subscribe to Delaware Business Times and save 50%